A city in the south emerges as the Ozempic capital of the United States

The southern Kentucky city of Bowling Green has reportedly emerged as a major center for weight loss drugs like Ozempic, Wegovy and Mounjaro.

The share of people prescribed GLP-1 agonist drug prescriptions in and around Bowling Green in the past 12 months amounted to 4% at minimum, Bloomberg reported.

The “conservative” figure, the outlet said, was based on data from PurpleLab Inc. 

The anti-diabetic medication Ozempic, made by Danish pharmaceutical company Novo Nordisk, Feb. 23, 2023, in Paris  (Joel Saget/AFP via Getty Images / Getty Images)

In Brooklyn and Miami, 1% of residents get weight loss drug prescriptions, Bloomberg reported. 

CLICK HERE TO READ MORE ON FOX BUSINESS

The statewide weight loss drug prescription rate for Kentucky, at 6.8%, also topped other states in the U.S., according to the outlet.

Alabama, West Virginia,…

Read more…

spot_imgspot_img

Latest news

Related news

LEAVE A REPLY

Please enter your comment!
Please enter your name here